An advisory panel at the U.S. Centers for Disease Control and Prevention (CDC) has recommended a booster shot of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and for some adults with underlying medical conditions.
The vote by the group on Thursday clears the way for a booster roll-out to begin as soon as this week for millions of people who had their second dose at least six months ago.
It also follows Wednesday’s emergency use authorization from the U.S. Food and Drug Administration (FDA) for a booster shot of the Pfizer vaccine for seniors 65 and up and for certain adults at a
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/health/vaccine-booster-cdc-1.6187414?cmp=rss.